Brokerages Set Hercules Capital, Inc. (NYSE:HTGC) Target Price at $19.29

Shares of Hercules Capital, Inc. (NYSE:HTGC) have been assigned a consensus rating of “Moderate Buy” from the eight brokerages that are presently covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a hold recommendation, four have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $19.2917.

Several brokerages have recently commented on HTGC. Wells Fargo & Company reduced their price objective on Hercules Capital from $18.00 to $17.00 and set an “overweight” rating on the stock in a research report on Friday, February 13th. Wall Street Zen lowered Hercules Capital from a “buy” rating to a “hold” rating in a research note on Saturday, December 20th. Piper Sandler downgraded shares of Hercules Capital from an “overweight” rating to a “neutral” rating and decreased their price target for the stock from $20.50 to $17.50 in a research note on Friday, February 13th. Keefe, Bruyette & Woods lowered their price objective on shares of Hercules Capital from $20.00 to $19.00 and set an “outperform” rating for the company in a report on Friday, February 13th. Finally, Weiss Ratings cut shares of Hercules Capital from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, February 24th.

Hercules Capital Stock Performance

NYSE HTGC opened at $14.63 on Friday. Hercules Capital has a 52-week low of $13.77 and a 52-week high of $19.67. The company has a debt-to-equity ratio of 1.03, a quick ratio of 1.48 and a current ratio of 1.48. The company has a market capitalization of $2.69 billion, a P/E ratio of 7.99 and a beta of 0.87. The company has a fifty day moving average of $17.10 and a 200-day moving average of $17.94.

Hercules Capital (NYSE:HTGC) last released its earnings results on Thursday, February 12th. The financial services provider reported $0.48 EPS for the quarter, meeting analysts’ consensus estimates of $0.48. Hercules Capital had a return on equity of 15.97% and a net margin of 63.80%.The business had revenue of $133.25 million for the quarter, compared to analysts’ expectations of $141.57 million. During the same quarter in the prior year, the firm earned $0.49 earnings per share. As a group, equities research analysts predict that Hercules Capital will post 1.96 EPS for the current fiscal year.

Hercules Capital Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 4th. Shareholders of record on Wednesday, February 25th were given a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a yield of 1.9%. The ex-dividend date was Wednesday, February 25th. Hercules Capital’s dividend payout ratio is presently 87.43%.

Hercules Capital News Roundup

Here are the key news stories impacting Hercules Capital this week:

• Positive Sentiment: Analyst optimism / brokerage recommendations — Several recent pieces note that Wall Street’s average brokerage recommendation favors adding HTGC, which can support buying interest if investors follow sell‑side guidance. Is Hercules Capital (HTGC) a Buy as Wall Street Analysts Look Optimistic?
• Positive Sentiment: High yield + insider buys highlighted — Income‑oriented coverage (The Motley Fool) points to HTGC’s ultra‑high dividend yield and notes recent open‑market purchases by board/C‑suite insiders, which can be a bullish signal for yield investors. 1 Sizzling 12.7% Ultra-High-Yield Dividend Stock to Buy
• Neutral Sentiment: Valuation and role in funding tech/life sciences debated — Several analyses question whether HTGC’s current price reflects its niche as a BDC funding growth-stage tech and life‑sciences companies; these pieces frame risks and opportunity without clear directional impact. Is Hercules Capital (HTGC) Pricing Reflect Its Role Funding Tech And Life Sciences Growth?
• Negative Sentiment: Big jump in short interest — Short interest rose sharply in February to roughly 11.9M shares (up ~46.7% from mid‑February), equal to about 6.6% of shares and a 2.4‑day short‑interest ratio. Rising short activity increases selling pressure and volatility risk. Hercules Capital Faces Rising Short Interest As Valuation Discount Widens
• Negative Sentiment: Law‑firm investigation / potential litigation — Pomerantz LLP is investigating claims on behalf of HTGC investors, which can lead to legal costs, management distraction, and investor uncertainty if it develops into litigation. Pomerantz Law Firm Investigates Claims On Behalf of Investors of Hercules Capital
• Negative Sentiment: High‑profile media criticism — Prominent commentator Jim Cramer publicly warned viewers to avoid BDCs, specifically singling out names like HTGC; such commentary can amplify sentiment moves and attract more short sellers. Jim Cramer on Hercules Capital: “I Want You to Stay Away From These”

Insider Activity

In related news, CFO Seth H. Meyer bought 7,000 shares of the company’s stock in a transaction that occurred on Friday, February 27th. The stock was bought at an average cost of $14.33 per share, for a total transaction of $100,310.00. Following the acquisition, the chief financial officer directly owned 448,553 shares of the company’s stock, valued at $6,427,764.49. The trade was a 1.59% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Gayle A. Crowell purchased 6,600 shares of Hercules Capital stock in a transaction that occurred on Monday, February 23rd. The shares were bought at an average price of $15.20 per share, for a total transaction of $100,320.00. Following the completion of the transaction, the director owned 87,458 shares in the company, valued at $1,329,361.60. The trade was a 8.16% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last ninety days, insiders purchased 117,015 shares of company stock valued at $1,749,620. Company insiders own 1.80% of the company’s stock.

Institutional Trading of Hercules Capital

A number of institutional investors have recently made changes to their positions in HTGC. Sankala Group LLC bought a new position in shares of Hercules Capital in the fourth quarter worth approximately $76,000. Invesco Ltd. raised its holdings in Hercules Capital by 81.3% during the 4th quarter. Invesco Ltd. now owns 79,650 shares of the financial services provider’s stock valued at $1,499,000 after buying an additional 35,722 shares during the last quarter. Rare Wolf Capital LLC purchased a new stake in Hercules Capital during the 4th quarter valued at $1,036,000. Ameriflex Group Inc. bought a new stake in Hercules Capital in the 4th quarter worth $123,000. Finally, Beacon Pointe Advisors LLC grew its holdings in Hercules Capital by 29.8% in the 4th quarter. Beacon Pointe Advisors LLC now owns 42,447 shares of the financial services provider’s stock worth $799,000 after acquiring an additional 9,750 shares during the last quarter. Hedge funds and other institutional investors own 19.69% of the company’s stock.

Hercules Capital Company Profile

Hercules Capital, Inc is a specialty finance company organized as a business development company (BDC) that provides tailored debt financing solutions to high‐growth companies. Through its external management structure, Hercules Capital extends senior secured loans, subordinated debt and growth capital designed to support research and development, expansion initiatives and working capital needs. The firm primarily partners with venture capital and private equity sponsors to finance innovative enterprises across various developmental stages.

The company’s investment portfolio is concentrated in technology, life sciences and sustainable and renewable technology sectors, reflecting its focus on industries with strong growth prospects and recurring capital requirements.